Results 81 to 90 of about 83,105 (158)

Immune evasion by Kaposi’s sarcoma-associated herpesvirus

, 2010
Persistent viral infections are often associated with serious diseases, primarily by altering functions of the host immune system. The hallmark of Kaposi’s sarcoma-associated herpesvirus (KSHV) infection is the establishment of a life-long persistent ...
Parkash Gill, Preet M Chaudhary, Hye-Ra Lee, Jae U Jung, Stacy Lee   +4 more
core   +1 more source

Demographic and Histopathologic Study of Kaposi's Sarcoma in a Dermatology Clinic in the Years of 2006 to 2011

Acta Medica Iranica, 2014
Kaposi's sarcoma is a low-grade vascular tumor that its prevalence is increasing all around the world due to the increasing prevalence of HIV and organ transplantations.
Kambiz Kamyab, Amir Hooshang Ehsani, Arghavan Azizpour, Zahra Mehdizad, Zeinab Aryanian, Azadeh Goodarzi, Nessa Aghazadeh, Pardis Hejazi, Mehrnaz Salehi, Zahra Seyedain   +9 more
doaj  

Cardiovascular Disease Multimorbidity and Decreased Health‐Related Quality of Life in Haiti: A Cross‐Sectional Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Multimorbidity is increasingly prevalent in lower‐ and middle‐income countries. Health‐related quality of life (HRQOL) has been inversely associated with multimorbidity but is understudied in lower‐ and middle‐income countries.
Shalom Sabwa, Vanessa Rouzier, Rodney Sufra, Reichling St. Sauveur, Nour Mourra, Rehana Rasul, Joseph Inddy, Lily D. Yan, Madeline Sterling, Laura Pinheiro, Marie Deschamps, Jean William Pape, Margaret L. McNairy   +12 more
doaj   +1 more source

Modulation of oncogenic signaling networks by Kaposi’s sarcoma-associated herpesvirus

, 2017
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the etiological agent of three human malignancies: Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. To persist and replicate within host cells, KSHV encodes proteins that
Jason P. Wong, Blossom Damania
core   +1 more source

Clinical corse of classic Kaposi’s sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir.

, 2009
HIV protease inhibitors (HIV-PI) have been shown to exert anti-angiogenic and anti-tumor actions independently from their antiretroviral effect. Based on these studies, HIV-seronegative patients with classic Kaposi’s sarcoma were treated with Indinavir ...
Cencioni G, Salvi E, Tirelli U, Campagna M, the Concerted Action on Kaposi’s Sarcoma: Barillari G, Toschi E, De Pità O, Potenza C, Cuccuru MA, Sheldon J, Schulz T., Bramati M, Monini P, Grosso MG, Calmieri S, Martellotta F, Siriani MC, Leone P, Bacigalupo I, Moi L, Di Biagio A, Di Carlo A, Cottoni F, Strumia R, Del Giacco S, Brambilla L, Giuliani M, Simonelli C, Sarmati L, Clerico R, Piludu G, Ensoli B, Gatti G, Ferrucci S, Castelli L, Sgadari C, Bianchini G, Androni M, BORGHI, Alessandro, Bellino S, Moracci G, Pilla MA, Milzer J, Sabbatucci M   +43 more
core  

Lymphangiectatic Kaposi's sarcoma in a patient with AIDS Sarcoma de Kaposi linfangiectásico em paciente com Aids

Anais Brasileiros de Dermatologia, 2013
Kaposi's sarcoma is a malignant disease that originates in the lymphatic endothelium. It has a broad spectrum of clinical manifestations. Its four distinct clinical forms are: classic, endemic, iatrogenic and epidemic Kaposi's sarcoma.
Mônica Santos, Virginia Vilasboas, Luciana Mendes, Carolina Talhari, Sinésio Talhari   +4 more
doaj  

Oropharyngolaryngeal manifestations of Kaposi’s sarcoma with airway obstruction and its management in patients with HIV/AIDS

Revista Cubana de Medicina Militar
Introduction: Kaposi's sarcoma is one of the manifestations in HIV/AIDS patients which is found in the oropharyngolaryngeal region. This can be life-threatening because it can cause airway obstruction.
Alfi Syahri, Tintin Sukartini, Erna Dwi Wahyuni, Ninuk Dian Kurniawati, Fiki Muhammad Ridho   +4 more
doaj  

Is Kaposi's sarcoma the end of the OX40/OX40L axis in atopic dermatitis? [PDF]

Front Immunol
Salek-Ardakani S.
europepmc   +1 more source

Primary nasopharyngeal Kaposi's sarcoma without cutaneous manifestations: a case report. [PDF]

J Med Case Rep
Lugina EL, Ernesti ZM, Nundu EL, Mlole AT, Tupa F, StanleyNoah H, Mwita CJ, Mosha IJ, Iddy S, Kahesa CA, Ngalamika O, Wood C, Mwaiselage JD, Lidenge SJ.   +13 more
europepmc   +1 more source

Paraneoplastic dermatomyositis with Kaposi's sarcoma: A case report. [PDF]

SAGE Open Med Case Rep
Qian SY, Qin K, Desrochers J.
europepmc   +1 more source